Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.

Golombick, Terry

Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study. [electronic resource] - American journal of hematology May 2012 - 455-60 p. digital

Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial

1096-8652

10.1002/ajh.23159 doi


Aged
Aged, 80 and over
Amino Acids--urine
Antineoplastic Agents, Phytogenic--administration & dosage
Biomarkers
Bone Remodeling--drug effects
Creatinine--blood
Cross-Over Studies
Curcumin--administration & dosage
Disease Progression
Double-Blind Method
Female
Humans
Immunoglobulin Light Chains--analysis
Male
Middle Aged
Monoclonal Gammopathy of Undetermined Significance--blood
Multiple Myeloma--prevention & control
Myeloma Proteins--analysis
Parathyroid Hormone--blood
Treatment Outcome
Vitamin D--blood